Yesterday, shares of Horizon Pharma (NASDAQ:HZNP) were down more than 30% after two major pharmacy benefit managers removed its drugs from their formularies.
For the following two reasons, I do believe this could just turn into the beginning of a nightmare for HZNP shareholders:
http://unemon.com/ResearchEasy/20140729_HZNP_PART_III
Disclosure: The author is short HZNP.